US OptionsDetailed Quotes

MLTX250516P60000

Watchlist

0.00
0.000.00%

15min DelayClose Apr 29 09:30 ET

0.00High0.00Low

MoonLake Immunotherapeutics Stock Discussion

Teddy123

Apr 3 19:11

MoonLake Secures up to $500 Million in Non-Dilutive Financing from Hercules Capital and Announces a Capital Markets Update on April 29 to Provide Important Clinical Updates

$MoonLake Immunotherapeutics (MLTX.US)$
MoonLake Lands Massive $500M Deal: Game-Changing Clinical Updates Coming April 29

Movers and Shakers

Jan 17 22:01

Columns Today's Pre-Market Movers and Top Ratings | QRVO, MLTX, NET and More

Morning Movers
Gapping up
$Qorvo (QRVO.US)$ saw a 7% increase after reports of activist investor Starboard Value acquiring a 7.7% stake.
$MoonLake Immunotherapeutics (MLTX.US)$ gained over 4% following Goldman Sachs' upgrade to 'buy', citing positive expectations for its phase 3 trial data.
$Life360 (LIF.US)$ rose 3% following UBS's upgrade to 'buy', based on promising ad revenue potential.
$Rivian Automotive (RIVN.US)$ increased 2...

Meltyy

Jan 24, 2024 17:25

Ph2 readouts in Q1 2024...

$Pfizer (PFE.US)$ Phase 2
$Leap Therapeutics (LPTX.US)$ Phase 2
$Vera Therapeutics (VERA.US)$ Phase 2b
$4D Molecular Therapeutics (FDMT.US)$ Phase 2
$Adverum Biotechnologies (ADVM.US)$ Phase 2
$Denali Therapeutics (DNLI.US)$ Phase 2
$Akero Therapeutics (AKRO.US)$ Phase 2b
$Spruce Biosciences (SPRB.US)$ Phase 2
$Xencor (XNCR.US)$ Phase 2
$Alnylam Pharmaceuticals (ALNY.US)$ Phase 2
$Harmony Biosciences (HRMY.US)$ Phase 2
$Annexon (ANNX.US)$ Phase 2a
$Roivant Sciences (ROIV.US)$...

Meltyy

Jan 3, 2024 20:11

Upcoming Ph 2 readouts in Q1 2024…

$Cellectar BioSciences (CLRB.US)$ Phase 2
$Regenxbio (RGNX.US)$ Phase 2
$Leap Therapeutics (LPTX.US)$ Phase 2
$4D Molecular Therapeutics (FDMT.US)$ Phase 2
$Adverum Biotechnologies (ADVM.US)$ Phase 2
$Denali Therapeutics (DNLI.US)$ Phase 2
$EyePoint Pharmaceuticals (EYPT.US)$ Phase 2
$Xencor (XNCR.US)$ Phase 2
$Harmony Biosciences (HRMY.US)$ Phase 2
$Alnylam Pharmaceuticals (ALNY.US)$ Phase 2
$Disc Medicine (IRON.US)$ Phase 2
$Atea Pharmaceuticals (AVIR.US)$ Phase 2
$Allakos (ALLK.US)$ Phase 2...

Moomoo AI

Oct 16, 2023 19:34

MoonLake's CEO expresses confidence in 120mg being the optimal dose and highlights the drug's improved durability of response compared to Humira in other studies.

MoonLake Stock Rises After Skin Disorder Drug Shows Promise in Phase 2 Trial

Weight-loss drugmakers report strong earnings: Boon or bane?

Rivera

Aug 16, 2023 20:21

Caming up

$MoonLake Immunotherapeutics (MLTX.US)$

Mcsnacks H Tupack

Jun 29, 2023 16:14

Long and short

The long stock would be $Bruush Oral Care (BRSH.US)$. First its goal is to regain compliance over a 1.00. Second it has a new line of products to boost its next ER. Third the upside beats the downside. 500% in gains.
The short stock would be $MoonLake Immunotherapeutics (MLTX.US)$ It has just seen its highest run. Once it gets above 50.00 its loses investors interest.

Trading idea competition: What is pairs trading strategy?

BAG-HOLDER

Jun 26, 2023 22:01

$MoonLake Immunotherapeutics (MLTX.US)$ I have this skin condition, Hopefully they keep having good results with their medication. Hopefully this stock really flies again off this news.

CowBeiCowBu

Jun 26, 2023 20:51

$MoonLake Immunotherapeutics (MLTX.US)$ the end.

No comment yet